Here we report the design of tumor‐responsive nanoscale coordination polymer (NCP) core‐shell nanoparticles[13] for the enhanced delivery of oxaliplatin (OxPt) and SN38, an active metabolite of irinotecan, to tumors by targeting LDLR. This evidence concerns the gene LDLR and neoplasm.